Little is known about the epidemiology of anxiety among older adults living in low- and middle-income countries. This disorder, which can substantially impair quality of life^[@R1]^ and has also been associated with increased risk of mortality^[@R2],[@R3]^ and disability,^[@R4]^ is thought to decrease with age^[@R5]^ but it still common among older people living in high-income countries.^[@R6]^ It is not known whether similar patterns occur across the world. A recent systematic review of anxiety^[@R6]^ in later life only reported studies conducted in high-income countries, and we are aware of only a handful of studies that estimated the prevalence of anxiety outside those settings.^[@R7]--[@R10]^ The 10/66 study provides an opportunity to estimate anxiety in diverse settings but using a standardised and validated methodology. We also aimed to investigate sociodemographic factors and health statuses associated with both clinical and subclinical anxiety and the impact that this condition has on disability. We anticipated finding a lower prevalence of anxiety in low- and middle-income countries but expected it to be as disabling as it is in high-income countries.

Method {#S1}
======

Study design {#S2}
------------

Cross-sectional surveys of all residents aged 65 or over (*n* = 15 021) in 11 catchment areas in 7 countries (China, India, Cuba, Dominican Republic, Venezuela, Mexico and Peru) were carried out as part of the baseline phase of the 10/66 Dementia Research Group's population-based programme. The full protocol has been published elsewhere.^[@R11]^ Catchment area sites were selected purposively with a view to identifying typical central urban high density, and predominately low socioeconomic status districts in national or state capital cities (Beijing in China, Chennai in India, Havana and neighbouring Matanzas in Cuba, Santo Domingo in Dominican Republic, Caracas in Venezuela, Mexico City in Mexico and Lima in Peru) and contrasting rural areas, with a traditional agrarian lifestyle and low-density population in the four countries where this was feasible (villages around Vellore in India, Daxing in China, Morelos state in Mexico, and Canete in Peru). The boundaries of each catchment area were precisely defined, and households mapped. Each household was then systematically door-knocked to identify all those aged 65 years and over, who were then considered eligible for participation in the survey. The response rate was excellent in most centres and ranged from 72 to 98% (average 86%). After the consent was taken the full assessment, lasting 2--3 h, was carried out. This included a physical examination, a blood test and the informant and participant interviews. Ethical approval was sought and received from the King's College London ethics committee and by local ethics committees.

Interviews and measurements {#S3}
---------------------------

The interviews, translated into the different languages, lasted around 2--3 h and collected data necessary to: mental disorders diagnoses (including dementia, depression and anxiety), measurement of comorbid physical illnesses, sociodemographics, risk factors specific to dementia and chronic diseases, health-service usage, disability, care arrangements and caregiver strain.^[@R11]^ All the scales were translated, back-translated and tested for conceptual uniformity and acceptability, and finally reviewed by local informants.

Sociodemographics {#S4}
-----------------

Age was assessed from formal documents, informant report and, in cases of incongruity, an event calendar. The marital status and gender of the participants, together with the complete list of coresidents, including ages and relationship, were also collected. Socioeconomic status was recorded by measuring a number of variables, including level of education (none/minimal/completed primary/completed secondary/tertiary), income and sources of income, occupational status and food insecurity. Place of birth and residence during adult and later years were also recorded.

Mental health {#S5}
-------------

Anxiety was measured by using the Geriatric Mental State Examination (GMS) and its associated diagnostic algorithm: the Automated Geriatric Examination for Computer Assisted Taxonomy (AGECAT).^[@R12],[@R13]^ The AGECAT algorithm produces a computerised psychiatric diagnosis from data collected in the full GMS interview. All the symptom components are grouped into one of eight diagnostic 'clusters', with level of diagnostic confidence of 0--5 allocated to the subject of each cluster. The clusters are: organic brain syndrome (dementia); schizophrenia; mania; neurotic and psychotic depression; and obsessional, hypochondriac, phobic, and anxiety neuroses. Scores of 3--5 denote probable cases, 1 and 2 denote subcases, and 0 denotes no or negligible relevant symptoms. Agreement between psychiatrists and AGECAT in making diagnostic decisions has been shown to be high in several studies on different populations.^[@R12],[@R13]^ The focus for the GMS, as its name implies, is 'state', specifically, symptoms present in the previous 1 month, and although the GMS does not map precisely onto the DSM or ICD categories, it was calibrated for the detection of disorders of clinical severity, and it has been used in several studies^[@R9],[@R14],[@R15]^ to describe generalised anxiety disorder.

The prevalence of anxiety was defined as the frequency of existing cases of anxiety in the given population. Those having a score of at least three in the GMS/AGECAT Stage I anxiety cluster, which is intended to correspond to clinical levels of anxiety,^[@R12]^ were considered as 'cases'. Subthreshold disorders (e.g. scores of one and two in the GMS/AGECAT Stage I anxiety cluster), which did not reach clinical levels, were also analysed and reported. Dementia was measured by using the 10/66 algorithm.^[@R16]^ The ICD-10^[@R17]^ criteria derived from a computerised algorithm applied to the GMS were used to categorise participants with depression.

Other measures {#S6}
--------------

Activity limitation and participation restriction was estimated by using the World Health Organization Disability Assessment Schedule II (WHODAS-II),^[@R18]^ developed by WHO as a culture-fair assessment to use in cross-cultural studies. We also measured whether the informant perceived any anxiety in the participants and the level of distress that this caused. This was done by including the Neuropsychiatric Inventory Questionnaire (NPI)^[@R19]^ questions: 'Does your (xxxx) become upset when separated from you? Does he or she have any other signs of nervousness, such as shortness of breath, sighing, being unable to relax, or feeling excessively tense?'. The distress level that was experienced by the informant was rated as no distress, minimal, mild, moderate, severe and extreme. The prevalence of perceived anxiety was reported and correlated with the GMS/AGECAT diagnoses.

Statistical analyses {#S7}
====================

Version 2.1 of the 10/66 data archive was used for all the analyses, which were carried out in STATA (version 10.1) for Windows. The prevalence of GMS/AGECAT Stage I anxiety syndrome was described and stratified by age and gender and robust 95% confidence intervals adjusted for household clustering were reported. The standardised prevalence was also reported, to allow comparisons to be made across the study sites, after adjustment for the compositional effects of age, gender and education.

We modelled potential risk factors by using Poisson regression models, which were fitted for each country and provided mutually adjusted prevalence ratios. A fixed-effects meta-analysis was used to combine the countries' prevalence ratios, and an estimate of heterogeneity was provided by the Higgins *I*^2^.^[@R20]^

Level of agreement between the GMS/AGECAT diagnoses and the informant reports were measured by kappa statistics and reported with their 95% CIs. Spearman's rank correlations of NPI severity scores on the anxiety item and the AGECAT anxiety scores were also calculated.

Finally we investigated whether anxiety had an impact on disability by analysing the distribution of mean WHODAS disability scores, which were reported with their standard deviations. Having 15 days or more of disability in the previous month was defined as severe disability. We then ran Poisson regression models, adjusted for age, gender, 10/66 dementia and number of comorbid illnesses in participants with anxiety and subthreshold anxiety, setting the reference as being free from anxiety. This analysis was also adjusted for ICD-10 depression to see whether there was an independent effect of anxiety on disability scores. Population-attributable prevalence fractions were calculated within the Poisson regression framework by using the Stata aflogit command, which also allows adjustment for confounders. Population-attributable prevalence fractions provide the proportion of existing severe disability that might be averted if that exposure was avoided.

Results {#S8}
=======

Sample characteristics {#S9}
----------------------

A total of 15 021 interviews were carried out. In all sites, women outnumbered men (62% women) (online Table DS1). A higher proportion of older people was recorded in South America (in particular Cuba, Dominican Republic, Peru and Mexico), a sign that demographic ageing is more advanced. Higher levels of completed education were registered in the urban areas of all centres, whereas minimal or low education was common in rural areas. Food insecurities were relatively common in India (14.1% in rural *v.* 20.8% in urban India), rural Peru (13.5%) and Dominican Republic (12.1%). The number of missing values was very low (online Table DS1).

Prevalence of anxiety {#S10}
---------------------

The prevalence of anxiety estimated by Stage I GMS/AGECAT diagnoses is shown in [Fig. 1](#F1){ref-type="fig"}. The crude prevalence ranged from 0.2 to 8.9%, where China had the lowest, and Dominican Republic the highest estimates. Standardisation did not affect the figures radically: rural China remained the area with the lowest prevalence (0.1%), whereas urban Peru had the highest with 9.6%. Women had a higher prevalence of anxiety (both clinical and subclinical levels) in all sites (online Table DS2). The prevalence estimate of comorbid anxiety and depression ranged from 0.3% (rural India) to 4.5% (urban Peru); we exclude China as the number of cases was negligible ([Fig. 1](#F1){ref-type="fig"}). Comorbid depression in participants with anxiety was quite high, and reached almost 50% in Dominican Republic (online Table DS2). In all centres more than one-fifth of anxiety was comorbid with depression. The distribution of anxiety symptoms that did not reach clinical significance was also measured (online Table DS3). Most centres, with the exception of China and rural India, had a prevalence of subthreshold anxiety well above the 30% mark, and in a number of sites this estimate was closer to almost one-half of the population. The severity of anxiety in the Latin centres was also higher. In total 235 cases of severe anxiety (2.3% prevalence), corresponding to level 4 of the GMS/AGECAT output, and 110 cases of very severe anxiety (1.0% prevalence), equivalent to level 5 of the GMS/AGECAT schedule, were found within Latin America. In India on the other hand the prevalence of severe anxiety was less than half (0.7%) and the estimate for very severe anxiety was only 0.2%.

Factors associated with anxiety {#S11}
-------------------------------

Factors associated with anxiety were investigated in each country and meta-analysed estimates are found in [Table 1](#T1){ref-type="table"}. We could not estimate prevalence ratios for the Chinese centres, as too few cases occurred. For this reason, the data from China were not included in other analyses.

Similar patterns were found across the sites, although the magnitude of associations changed. Younger age, female gender and lower education were all associated with higher anxiety prevalence. The association between female gender and anxiety was strongest in Cuba and India (prevalence ratio (PR) = 2.0), whereas the inverse relationship between anxiety and age was primarily found in the Cuban and Venezuelan sites.

The factors that had stronger associations with anxiety after pooled estimations were food insecurity PR = 1.8 (95% CI 1.4--2.1), increasing number of physical impairments PR = 2.3 (95% CI Fig. 1Age-, gender- and education-standardised prevalence (95% CI) of Geriatric Mental State Examination/Automated Geriatric Examination for Computer Assisted Taxonomy (GMS/AGECAT) Stage I anxiety, and percentage of comorbid ICD-10 depression. 2.1--2.6) and having a diagnosis of dementia PR = 1.5 (95% CI 1.2--1.8). Living in an urban environment, as measured in Peru, Mexico and India, was associated with the highest prevalence: PR = 3.3 (95% CI 2.0--5.0).

The protective effect of rural environments was explored in more depth in [Table 2](#T2){ref-type="table"}. We estimated the prevalence of anxiety and calculated adjusted prevalence ratios in participants living in urban settings when the surveys were conducted, but who had lived in rural environments during their lives. The prevalence of anxiety was inversely linked to the length of residence in rural settings ([Table 2](#T2){ref-type="table"}). However, after adjustment for potential confounders this trend was not found to be statistically significant.

Recognition of anxiety by informants {#S12}
====================================

When we asked the informants to assess whether the participants suffered from anxiety (NPI), we found a two- to threefold increase in the prevalence of anxiety compared with the estimates obtained by using the GMS/AGECAT system ([Table 3](#T3){ref-type="table"}). A total of 40% of the informants were children of the participants, 30% spouses, 8% sonsor daughters-in-law, 4% siblings and the rest included other relatives, friends and neighbours. Anxiety was identified by the informants in less than 40% of GMS anxiety cases, with the lowest prevalence of 22.2% in India and the highest of 38.5% in Cuba. Between 6.4% (India) and 18.2% (Cuba) of the informants thought that the participants suffered from anxiety when not confirmed by the GMS/AGECAT diagnosis. We therefore checked whether these informants were recognising different symptoms, such as depression or subclinical anxiety. More than one-half of those who did not have a GMS/AGECAT anxiety diagnosis had either subclinical levels of anxiety (36.9%) or ICD-10 depression (15.1%). Kappa values showed very slight agreements between the two different measurements ([Table 3](#T3){ref-type="table"}), but greater than predicted by chance alone in all the centres. These values did not significantly change when participants with subclinical level of anxiety were included (data not shown).

###### 

Meta-analysed mutually adjusted prevalence ratio (PR) estimates (95% CI) from a Poisson regression for the independent effects of age, gender, socioeconomic status, dementia diagnosis and number of physical illnesses on Geriatric Mental State Examination/Automated Geriatric Examination for Computer Assisted Taxonomy (GMS/AGECAT) anxiety prevalence

                                               Age (5-year groups)   Male gender      Education        Married or cohabiting   Food insecurity   Physical illnesses, *n*   Dementia diagnosis   Living in a rural area
  -------------------------------------------- --------------------- ---------------- ---------------- ----------------------- ----------------- ------------------------- -------------------- ------------------------
  Location, PR (95% CI)                                                                                                                                                                         
      Cuba                                     0.7 (0.6--0.8)        0.3 (0.2--0.5)   0.9 (0.7--1.1)   0.9 (0.8--1.1)          1.4 (0.8--2.5)    2.1 (1.6--2.8)            1.1 (0.6--1.9)       n/a
      Dominican Republic                       0.9 (0.8--1.0)        0.8 (0.6--1.2)   1.0 (0.6--1.2)   0.9 (0.8--1.1)          2.1 (1.5--2.7)    2.9 (2.7--3.6)            1.3 (0.9--1.9)       n/a
      Peru                                     0.9 (0.7--1.0)        0.5 (0.3--0.8)   0.9 (0.8--1.1)   1.0 (0.8--1.1)          2.1 (1.3--3.4)    2.4 (2.0--3.1)            1.7 (1.0--2.7)       0.3 (0.2--0.6)
      Venezuela                                0.8 (0.7--0.9)        0.7 (0.4--1.0)   1.0 (0.8--1.2)   0.9 (0.8--1.1)          1.7 (1.1--2.7)    3.4 (2.6--4.5)            3.0 (1.9--4.7)       n/a
      Mexico                                   0.8 (0.7--1.0)        0.5 (0.3--0.8)   0.9 (0.7--1.1)   1.1 (0.9--1.1)          1.4 (0.7--2.7)    2.2 (1.6--2.9)            1.6 (1.0--2.7)       0.6 (0.4--1.0)
      India                                    1.0 (0.8--1.4)        0.3 (0.1--0.6)   0.9 (0.6--1.4)   1.1 (0.8--1.5)          1.7 (0.9--3.1)    1.3 (0.8--2.2)            2.5 (1.3--4.6)       0.2 (0.2--0.5)
      China^[a](#TFN1){ref-type="table-fn"}^   --                    --               --               --                      --                --                        --                   --
                                                                                                                                                                                                
  Meta-analysed estimate, PR (95% CI)          0.8 (0.8--0.9)        0.5 (0.4--0.6)   0.9 (0.8--1.0)   1.0 (0.9--1.1)          1.8 (1.4--2.1)    2.3 (2.1--2.6)            1.5 (1.2--1.8)       0.3 (0.2--0.5)
                                                                                                                                                                                                
  χ^2^ test for heterogeneity (*P*)            12.7 (0.03)           14.3 (0.01)      1.06 (0.96)      3.9 (0.56)              2.4 (0.80)        16.7 (0.006)              8.1 (0.15)           4.3 (0.12)
                                                                                                                                                                                                
  Higgins *I*^2^, %                            60.6                  65.1             0.0              0.0                     0.0               69.1                      38.0                 53.8

n/a, not applicable.

China: too few cases to estimate parameters.

###### 

The relationship between anxiety and migrations from rural to urban environments

                                                                         Participants in urban environment at time of survey                                     
  ---------------------------------------------------------------------- ----------------------------------------------------- ---------------- ---------------- -----------------
  Participants, *n*                                                      7893                                                  1880             386              73
                                                                                                                                                                 
  Anxiety prevalence ratios (95% CI)                                     6.5 (6.0--7.0)                                        6.3 (5.3--7.5)   5.7 (3.6--8.5)   5.5 (1.5--13.4)
                                                                                                                                                                 
  Adjusted prevalence ratios^[a](#TFN2){ref-type="table-fn"}^ (95% CI)   1.0 (Reference)                                       0.9 (0.8--1.0)   0.7 (0.4--1.1)   1.3 (0.5--3.1)

Adjusted for age, gender, education, marital status, number of assets, food insecurities, number of physical illnesses, 10/66 dementia, ICD-10 depression and country.

###### 

Concordance between Geriatric Mental State Examination/Automated Geriatric Examination for Computer Assisted Taxonomy (GMS/AGECAT) and informant report

                       GMS^[a](#TFN3){ref-type="table-fn"}^ prevalence (95% CI)   NPI^[b](#TFN4){ref-type="table-fn"}^ prevalence (95% CI)   GMS anxiety identified by the informant, % (*n/N*)   Anxiety identified by informant not confirmed by GMS, % (*n/N*)   Kappa agreement (95% CI)
  -------------------- ---------------------------------------------------------- ---------------------------------------------------------- ---------------------------------------------------- ----------------------------------------------------------------- --------------------------
  Cuba                 4.2 (3.5--4.9)                                             19.1 (17.7--20.5)                                          38.5 (47/122)                                        18.2 (509/2793)                                                   0.08 (0.04--0.11)
  Dominican Republic   8.7 (7.4--9.9)                                             18.2 (16.5--19.9)                                          30.2 (54/179)                                        17.3 (316/1829)                                                   0.09 (0.04--0.13)
  Peru                 7.0 (5.9--8.2)                                             14.0 (12.5--15.6)                                          24.3 (33/136)                                        13.3 (238/1795)                                                   0.08 (0.03--0.13)
  Venezuela            7.7 (6.5--8.9)                                             12.7 (11.2--14.2)                                          24.5 (40/157)                                        12.1(215/1782)                                                    0.10 (0.05--0.16)
  Mexico               5.1 (4.2--6.2)                                             17.4 (15.0--19.1)                                          34.6 (36/104)                                        16.5 (313/1899)                                                   0.09 (0.04--0.13)
  India                2.3 (1.7--2.9)                                             6.7 (5.7--7.9)                                             22.2 (10/45)                                         6.4 (125/1953)                                                    0.08 (0.02--0.14)

NPI, Neuropsychiatry Inventory Questionnaire.

Crude prevalence of participants with a diagnosis of anxiety as confirmed by the GMS/AGECAT.

Crude prevalence of participants identified with anxiety by the informant.

Subjective distress caused to the informant by the participants' anxiety was also measured. As expected, the informants of those who had a confirmed GMS/AGECAT diagnosis reported the distress to be significantly higher than those where the GMS anxiety symptoms did not reach clinical levels (*P*-value for the paired *t*-test was 0.026 (*t* = 3.13, d.f. = 5)). Spearman rank correlations of NPI severity scores and AGECAT anxiety scores showed slight to fair correlations (range of Spearman's rho (ρ) = 0.13--0.22).

The impact of anxiety on disability {#S13}
-----------------------------------

In order to investigate the effect of anxiety on disability we reported the distribution of mean WHODAS disability scores in participants with anxiety, subthreshold anxiety and those without symptoms ([Table 4](#T4){ref-type="table"}). Anxiety symptoms that did not reach diagnostic levels had intermediate scores across the sites, whereas the means for participants with anxiety were almost double compared with those without anxiety. This was confirmed by running Poisson regressions across the sites. All the prevalence ratios were adjusted for age, gender, 10/66 dementia, number of physical illnesses and ICD-10 depression. Having an anxiety syndrome was significantly associated with severe disability in all centres with the exception of Peru. Subthreshold anxiety was also associated with severe disability in all centres. The contribution of anxiety (both threshold and subthreshold) to severe disability was high, as recorded by the population-attributable prevalence fractions: between 2.3% (Cuba) and 46.8% (India) of the prevalence of severe disability could be independently attributed to anxiety. Subthreshold anxiety had higher Table 4Distribution of disability scores (World Health Organization Disability Assessment Schedule II (WHODAS-II)), by Geriatric Mental State Examination/Automated Geriatric Examination for Computer Assisted Taxonomy (GMS/AGECAT) anxiety status across different countriesSevere disability (15 or more disability days in the past month)*n* (%)WHODAS-II score, mean (s.d.)*n*/N (%)Adjusted prevalence ratio^[a](#TFN5){ref-type="table-fn"}^ (95% CI)Population-attributable prevalence fraction (95% CI)Cuba    No anxiety1689 (57.4)9.4 (17.3)221/1664 (13.3)1.0 (reference)--    Subthreshold anxiety1131 (38.4)18.0 (21.9)256/1115 (23.0)1.1 (0.9--1.3)4.5 (0.0--9.9)    Anxiety124 (4.2)25.2 (22.5)35/124 (28.2)1.1 (0.7--1.8)2.3 (1.1--5.5)Dominican Republic    No anxiety788 (39.2)8.2 (14.4)64/787 (8.1)1.0 (reference)--    Subthreshold anxiety1044 (51.9)19.8 (20.9)184/1041 (17.7)1.5 (1.1--2.0)18.0 (5.3--29.0)    Anxiety179 (8.9)33.2 (23.0)63/178 (35.4)2.0 (1.2--3.2)12.0 (5.4--18.2)Peru    No anxiety941 (48.7)9.7 (18.5)206/742 (27.8)1.0 (reference)--    Subthreshold anxiety856 (44.3)13.2 (18.3)182/649 (28.0)0.9 (0.7--1.2)--    Anxiety136 (7.0)25.2 (21.9)18/98 (18.4)0.4 (0.2--0.8)--Venezuela    No anxiety878 (44.7)5.1 (9.5)48/782 (6.1)1.0 (reference)--    Subthreshold anxiety929 (47.3)13.4 (17.4)109/805 (13.5)1.9 (1.4--2.8)32.7 (19.8--43.5)    Anxiety158 (8.0)26.8 (24.3)26/134 (19.4)2.5 (1.3--5.0)12.5 (4.2--20.1)Mexico    No anxiety1068 (53.3)7.3 (14.9)67/1056 (6.3)1.0 (reference)--    Subthreshold anxiety831 (41.5)13.4 (20.1)114/821 (13.9)1.6 (1.2--2.2)23.8 (10.6--35.0)    Anxiety104 (5.2)20.3 (24.6)23/104 (22.1)2.5 (1.4--4.4)15.6 (7.4--23.1)India    No anxiety1171 (58.4)16.3 (17.3)98/1027 (9.5)1.0 (reference)--    Subthreshold anxiety787 (39.3)23.4 (20.4)147/751 (19.6)2.9 (2.3--3.7)46.8 (39.2--53.4)    Anxiety46 (2.3)29.5 (24.6)16/39 (41.0)3.3 (1.9--5.8)33.1 (10.0--55.9)[^1] population-attributable prevalence fractions, given the higher prevalence of subthreshold anxiety in the populations.

Discussion {#S14}
==========

Main findings {#S15}
-------------

This work showed that anxiety is a relatively common disorder among older people, particularly in survey sites in Latin America. The prevalence estimates of anxiety had a similar range to those found in high-income countries, with the exception of China where the prevalence in the older population was negligible. Two previous studies^[@R14],[@R15]^ conducted in Europe reported anxiety using the GMS/AGECAT diagnostic system, finding prevalence estimates of 3.2% and 4.0% in the Dutch and British populations respectively. This paper showed that India (rural and urban) and rural Peru had slightly lower estimates (between 0.8 and 3.0%), whereas the other Latin American sites (Cuba, Dominican Republic, urban Peru, Venezuela and Mexico) had a slightly higher prevalence (range: 4.9--9.6%) than the European studies.

We also found similar anxiety risk factors as those present in the literature, with gender, socioeconomic determinants and comorbid physical illnesses being the most important. Women were reported to have a twofold increase in prevalence of anxiety compared with men. Genetic and biological factors have been proposed to account for this variation, in particular relating to hormones, but also to psychological and social factors.^[@R21]^ It is possible that women might experience greater stress, associated with their societal role and that especially in low- and middle-income countries they might have less chance to escape, avoid and modify a stressful environment. Further research that analyses the interaction between social environment and gender in countries with diverse environments (for example, religious, economic, political) is thus needed. There was an inverse relationship between socioeconomic status and the prevalence of anxiety, in particular with education level and food insecurity, in line with the findings in high-income countries. We also found differences between rural and urban areas, with urban areas having a higher prevalence. It is thought that urban environments are more stressful than rural as the rates of crimes, substandard housing, noise pollution, inadequate services and 'social pathologies' are higher in these places.^[@R22],[@R23]^ Social support and social interaction are also known to be higher in rural areas,^[@R24]^ with denser networks, more often kin based and associated with religious institutions.^[@R25]^ However, we cannot exclude the possibility that the differences seen in urban and rural areas are due not to dissimilarities in the settings themselves, but to differences in terms of demographic variables (for example, ethnicity, age and family status) between the people living in those environments. Even after adjustment in the statistical models some residual confounders may still linger. We also found that among the people who lived in urban settings those who had previously lived in rural environments for longer had the lowest prevalence of anxiety, suggesting a cumulative protective effect of the surrounding environment. After adjustment for potential confounders, this relationship changed only for people who had been living in a rural environment at age 60. Although this was not statistically significant, it potentially indicates that moving to a new environment later in life could contribute to increased stress and anxiety symptoms.

We also found a significant association between disability and anxiety. This association was found with subthreshold disorders too, confirming the idea that people with subthreshold syndromes are still affected and impaired, and that if we were to treat and manage subclinical symptoms we could reduce the burden of disability. In this analysis we also adjusted for comorbid depression to show that the association between anxiety and disability still holds after accounting for depression, therefore indicating an independent effect of anxiety. The concordance between informant report and anxiety was modest. This suggests that caregivers might have difficulty in recognising the symptoms, therefore hindering a possible route to recognition and treatment.

An interesting result was the low prevalence of anxiety in China. Other studies found extremely low prevalence of mental disorders in China,^[@R7],[@R8]^ and it is possible that the stigmatisation of mental illnesses that has been described in this Asian culture^[@R26]^ can partially explain this phenomenon. Besides, the recruited participants were elderly people who had experienced the Great Proletarian Cultural Revolution (1966--1976), a period when 'it was considerably ideologically undesirable to be depressed'^[@R27]^ and when depressive symptoms were denounced as the manifestation of 'magnified individualism that cut people off from the masses' and criticised as absenteeism, indolence and detachment from a more proletarian mindset.^[@R28]^ In any event, external signs of psychological distress were culturally unacceptable in the Chinese culture even before the Cultural Revolution, so this theory cannot fully explain our findings. Chuan *et al*^[@R10]^ found a very low prevalence of GMS anxiety in Singapore, based on a mixed Chinese, Malay and Indian population, suggesting that this phenomenon may be common across Asian countries. Comparison with other countries of similar backgrounds could have helped in identifying and explaining our results, but unfortunately this was not possible in this study. Another issue may be one of cultural idioms for distress, which could be different particularly among older people and those living in rural areas and which have been largely described in the post-Kleinman literature on *shenjing shuairuo* ('nerve weakness').^[@R26],[@R29],[@R30]^

Strengths and limitations {#S16}
-------------------------

A key strength of this study was the ability to compare prevalence of anxiety in low- and middle-income countries using a measurement instrument specifically created for the cross-cultural assessment of mental health in older people. The protocols, the measurement and the diagnosis algorithm used in each centre were the same and this was specifically done to have a fair way of comparing estimates derived from different countries. Having each centres' principal investigators collectively trained and supervised also helped in maintaining a high internal validity within the study. Missing values were not a particular concern in this project, as the number was minimal, and unlikely to have undermined the findings. The only exception was for the severe disability variable; a modest number of missing values were present in the Peruvian centre, which could possibly account for the lower prevalence ratios found.

Some limitations, however, affect this study. The use of catchment areas helped in achieving a high response rate but its drawback is the theoretical loss of generalisability that could have affected our results, as the findings might not be applicable outside these areas and similar districts. It is very difficult to generalise these results to other low- and middle-income countries. Moreover, rural/urban differences could only be explored in three centres.

Although the validation of the GMS/AGECAT diagnostic system for dementia and mood disorders has been substantial,^[@R13]^ its validity for anxiety in low- and middle-income countries is somewhat lacking. It would have been appropriate to do a small validation study for the GMS schedule in a subgroup population of the 10/66 sample, to see if good sensitivity and specificity were maintained, but this was not the primary objective of the 10/66 study and it was therefore not carried out. There is no current gold standard for the measurement of anxiety disorders in older people in low- and middle-income countries and even full clinical diagnoses (DSM-IV^[@R31]^ and ICD-10) might not fully embrace the cultural aspects and the clinical spectrum of neuroses in later life. Furthermore, in the GMS schedule the 6-month time component (i.e. symptoms most days for at least 6 months), which is required for the clinical diagnosis using the DSM-IV classification, is not present. The GMS version used (B3) also excludes other types of anxiety disorders such as phobias and panic disorders that could have had a different distribution.

Finally, we cannot completely exclude selection bias. It is possible that in some countries the incompatibility of mental disorders and social roles meant that people with anxiety were more likely to have time to take part in the study. Given the very high response rate across the different centres this scenario is unlikely, but it cannot be entirely excluded.

Clinical implications {#S17}
---------------------

The association between disability and the widespread prevalence of late-life anxiety that was found in our sample emphasises the large scale of this problem. However, most of these countries have minimal mental health facilities, do not have specific mental health policies and they do not allocate any specific budget to mental health.^[@R32]^ The estimate^[@R33]^ that less than 10% of older adults receive appropriate treatment for anxiety is likely to be lower in those settings.

Psychological therapies, including cognitive--behavioural therapy (CBT) and relaxation training, have been shown to be effective in older populations in systematic reviews.^[@R33],[@R34]^ The relative ease with which relaxation training can be delivered, together with its low cost, make it a prime candidate for use in low- and middle-income countries. Psychological therapies might also be preferred to drug treatment, which often has low uptake among elderly people. Fear of addiction, stigma, previous negative experiences and potential drug interactions have all been described to explain older adults' aversion to antidepressants.^[@R35]^ Although the majority of risk factors that we found were non-modifiable, stepped-care prevention approaches have been used successfully in high-income countries.^[@R36]^ It is still not known whether these could be effectively translated to other settings but further research will shed light on this.

One of the key steps in treatment provision is the effective recognition of distress. Family and carers share a role in facilitating access to health services by encouraging their distressed contacts to seek help from general practitioners. We were not expecting good agreement between the informant report and the GMS/AGECAT, because anxiety is an internalising disorder and the NPI examines externally observable signs, which would not necessarily match well with a clinical diagnosis. However, lack of symptom recognition highlights the potential role for awareness campaigns that focus on anxiety symptoms. The low agreement could also suggest that very few of the participants were diagnosed with anxiety prior to the study, which could represent lack of services, barriers to access or non-recognition by medical personnel.

This is the first study to assess anxiety and its correlates in older life in different low- and middle-income countries using the same methodology. Prevalence estimates across the sites varied, but were mostly in line with the estimates from high-income countries. As the demographic change will occur more rapidly in these countries, further research into the mental health of older people in low- and middle-income countries is essential, with the inclusion of other specific anxiety disorders. Future research, including the follow-up phase of this study, will give more clues on the course and natural history of anxiety. Temporal relationships between the different factors will also be established. The development of new cross-culture assessment tools capable of measuring common mental disorders will help in gaining more accurate estimates, and further research into evidence-based interventions, both of a clinical and public health nature, will drive treatment provision and disorder detection.
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[^1]: Adjusted for age, gender, number of physical illnesses, 10/66 dementia and ICD-10 depression.
